The Artificial Intelligence Research Center of Zhejiang University, under the leadership of Professor Wu, the leader of artificial intelligence in China, will focus on the key technologies of medical artificial intelligence in clinical big data, imaging and genomics, and strive to build a medical artificial intelligence service platform, cultivate third-party medical artificial intelligence service enterprises, form relevant industry norms and standards, and build a medical artificial intelligence higher education system.
As the head of the research center, Wu, president of Zhejiang University, believes that promoting the application of artificial intelligence technology in the medical and health field is of great significance for accelerating the breakthrough of major disease prevention and control technology, occupying a leading position in the development of emerging strategic industries related to biomedicine, protecting the safety of medical and health data in China and optimizing China's medical service system.
"We will take advantage of the basic advantages of Zhejiang University, cooperate with major medical institutions and academic leaders in an open manner, open up data sources, establish a multidisciplinary and multi-agency collaboration mechanism, and strive to make breakthroughs in key technologies of medical artificial intelligence as soon as possible." Wu said that Yi Rui will undertake to build the core competence of medical artificial intelligence with independent intellectual property rights, build the engine of medical artificial intelligence with independent intellectual property rights in China, and open cooperation with major medical institutions, experts in various disciplines and industries to form the "Chinese power" of medical artificial intelligence.